APOA1 Antikörper
-
- Target Alle APOA1 Antikörper anzeigen
- APOA1 (Apolipoprotein A-I (APOA1))
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser APOA1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Aufreinigung
- purified
- Immunogen
- Purified recombinant fragment of human APOA1 expressed in E. coli.
- Klon
- 5F4F5
- Isotyp
- IgG1
- Top Product
- Discover our top product APOA1 Primärantikörper
-
-
- Applikationshinweise
- ELISA: 1:10000, WB: 1:500 - 1:2000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Ascitic fluid containing 0.03 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- 4°C, -20°C for long term storage
-
-
The contribution of individual and pairwise combinations of SNPs in the APOA1 and APOC3 genes to interindividual HDL-C variability." in: Journal of molecular medicine (Berlin, Germany), Vol. 84, Issue 7, pp. 561-72, (2006) (PubMed).
: "Short-term dehydroepiandrosterone treatment increases platelet cGMP production in elderly male subjects." in: Clinical endocrinology, Vol. 64, Issue 3, pp. 260-4, (2006) (PubMed).
: "
-
The contribution of individual and pairwise combinations of SNPs in the APOA1 and APOC3 genes to interindividual HDL-C variability." in: Journal of molecular medicine (Berlin, Germany), Vol. 84, Issue 7, pp. 561-72, (2006) (PubMed).
-
- Target
- APOA1 (Apolipoprotein A-I (APOA1))
- Andere Bezeichnung
- APOA1 (APOA1 Produkte)
- Synonyme
- Alp-1 antikoerper, Apoa-1 antikoerper, Brp-14 antikoerper, Ltw-1 antikoerper, Lvtw-1 antikoerper, Sep-1 antikoerper, Sep-2 antikoerper, Sep2 antikoerper, apoA-I antikoerper, apoa antikoerper, apoa1 antikoerper, cb49 antikoerper, wu:fb33f01 antikoerper, zgc:103718 antikoerper, MGC64335 antikoerper, MGC89745 antikoerper, Apo-AI antikoerper, ApoA-I antikoerper, APOA1 antikoerper, LOC100136573 antikoerper, apoa-i antikoerper, ApoAI antikoerper, apolipoprotein A1 antikoerper, apolipoprotein A-I antikoerper, apolipoprotein A-Ia antikoerper, apolipoprotein A-I S homeolog antikoerper, apolipoprotein A4 antikoerper, APOA1 antikoerper, Apoa1 antikoerper, apoa1a antikoerper, apoa1.S antikoerper, apoa1 antikoerper, LOC100136573 antikoerper, apoa-i antikoerper, apoa4 antikoerper
- Hintergrund
-
Description: APOA1: apolipoprotein A-I, it is the major protein component of high density lipoprotein (HDL) in plasma. The protein promotes cholesterol efflux from tissues to the liver for excretion, and it is a cofactor for lecithin cholesterolacyltransferase (LCAT) which is responsible for the formation of most plasma cholesteryl esters. Defects in the Apolipoprotein A I gene are associated with HDL deficiency and Tangier disease. The therapeutic potential of apoA-I has been recently assessed in patients with acute coronary syndromes, using a recombinant form of a naturally occurring variant of apoA-I. The availability of recombinant normal apoA-I should facilitate further investigation into the potential usefulness of apoA-I in preventing atherosclerotic vascular diseases.
Aliases: MGC117399
- Molekulargewicht
- 25 kDa
- Gen-ID
- 335
- HGNC
- 335
- Pathways
- Regulation of Lipid Metabolism by PPARalpha, Production of Molecular Mediator of Immune Response, Lipid Metabolism
-